Arkolith/Insider Trading/RGNX/Form 4

Karabelas Argeris N

DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Jul 30, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$166K
Net Open-Market Flow
-$166K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 29, 2024Sell(S)11K$15.05$166K11K
Jul 29, 2024Option exercise(M)11K$12.74$140K22K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 29, 2024Option exercise(M)11K—$02K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-005875) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML